PAFSC 1st Committee Recommends Approval for Social Anxiety Disorder for Lexapro

November 4, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs recommended approval for an additional indication of social anxiety disorder for Mochida Pharmaceutical’s Lexapro Tab. 10 mg (escitalopram) at a meeting on October 30. The reexamination period is...read more